⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2633198 | 1.00 | — | — | |
| SCHEMBL8586367 | 1.00 | — | — | |
| SCHEMBL10615283 | 0.76 | — | — | |
| SCHEMBL18556498 | 0.74 | ALDH1A1 (0.35) | — | |
| SCHEMBL17366365 | 0.74 | — | — | |
| SCHEMBL13607178 | 0.74 | — | — | |
| SCHEMBL4267030 | 0.73 | — | — | |
| SCHEMBL13073778 | 0.73 | — | — | |
| SCHEMBL14614830 | 0.73 | — | — | |
| SCHEMBL2186624 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0830161-B1 | NITRIC OXIDE-RELEASING NITROSO COMPOSITIONS AND METHODS AND INTRAVASCULAR DEVICES FOR USING THEM TO PREVENT RESTENOSIS | NOVOVASCULAR INC (US) | 2004-07-28 | — | — | EP | claimed |
| US-20230398517-A1 | NOVEL FORMO-PHENOLIC RESINS, PROCESS FOR THE PREPARATION THEREOF, AND USE OF SAME IN THE EXTRACTION OF URANIUM FROM WATER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-12-14 | — | — | US | disclosed |
| EP-3370518-B1 | COMPOSITIONS AND METHODS FOR REDUCING ICE CRYSTAL FORMATION | X THERMA INC (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-113049717-A | Fish oil adulteration identification method based on gas chromatography-ion mobility spectrometry | 南宁海关技术中心 | 2021-06-29 | — | — | CN | disclosed |
| WO-2021021055-A1 | COMBINATION OF OXOLAMINE AND TERBUTALINE | EGILMEZ MEHMET VEDAT (TR) | 2021-02-04 | — | — | WO | disclosed |
| EP-2804889-B1 | PROTON-CONDUCTING MEMBRANE, METHOD FOR THEIR PRODUCTION AND THEIR USE IN ELECTROCHEMICAL CELLS | BASF SE (DE) | 2019-03-13 | — | — | EP | disclosed |
| US-20180123155-A1 | PROTON-CONDUCTING MEMBRANE, METHOD FOR THEIR PRODUCTION AND THEIR USE IN ELECTROCHEMICAL CELLS | BASF SE (DE) | 2018-05-03 | — | — | US | disclosed |
| CN-107666898-A | AEROSOL HAIRSPRAY PRODUCT COMPRISING A SPRAYING DEVICE | 宝洁公司 | 2018-02-06 | — | — | CN | disclosed |
| US-9812725-B2 | Proton-conducting membrane and use thereof | BASF SE (DE) | 2017-11-07 | — | — | US | disclosed |
| US-20170234841-A1 | OPEN PORT SAMPLING INTERFACE | UT BATTELLE LLC (US) | 2017-08-17 | — | — | US | disclosed |
| WO-1998042682-A1 | NOVEL 1-AMINO-3 BENZYL URACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-01 | — | — | WO | disclosed |
| CN-1189824-A | 1-amino-3-benzyluracils | BASF AG (DE) | 1998-08-05 | — | — | CN | disclosed |
| WO-1998031681-A1 | 3-HETEROCYCLYL-SUBSTITUTED BENZOYL DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-23 | — | — | WO | disclosed |
| EP-0835248-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997035845-A1 | SUBSTITUTED 1-METHYL-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
| US-5622994-A | NITRONE DERIVATIVES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1997-04-22 | — | — | US | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
| EP-0496796-B1 | METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE | OKLAHOMA MED RES FOUND (US) | 1994-08-31 | — | — | EP | disclosed |
| EP-0496796-A1 | METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE. | OKLAHOMA MED RES FOUND (US) | 1992-08-05 | — | — | EP | disclosed |
| WO-1991005552-A1 | METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1991-05-02 | — | — | WO | disclosed |